Shaffer J E, Gorczynski R J
Can J Physiol Pharmacol. 1985 Jun;63(6):630-5. doi: 10.1139/y85-105.
The inotropic selectivity of dobutamine was examined in pentobarbital-anesthetized, vagotomized dogs pretreated with a ganglion blocker. The purpose was to determine if, in the presence of hexamethonium and vagotomy, the inotropic selectivity of dobutamine could be attributed to an action of dobutamine on alpha-adrenoreceptors. Dose-response curves were determined for either isoproterenol or dobutamine 30 min after treatment with hexamethonium (20mg/kg). Analysis of heart rate versus right ventricular contractile force showed that dobutamine produced less tachycardia for a given increase in contractile force than isoproterenol; this was statistically significant when contractile force was increased by either 50 or 100%. In a separate series of experiments, dobutamine (8 micrograms . kg(1-) . min(-1)) was administered 20 min after propranolol (3 mg/kg). Under these conditions there was a slight increase in contractile force which represented 12% of the dobutamine response prior to propranolol administration. This increase in contractile force in the presence of propranolol was completely prevented by the addition of phentolamine (1 mg/kg). Consequently, in another series of experiments, dose-response curves for dobutamine were performed in the presence of hexamethonium before and 30 min after phentolamine alone (1 mg/kg) or vehicle. Phentolamine did not influence the effect of dobutamine on heart rate or contractile force, but prevented the increase in diastolic blood pressure caused by dobutamine. In addition, analysis of heart rate versus contractile force indicated that there were no statistically significant effects of phentolamine on the inotropic selectivity of dobutamine.(ABSTRACT TRUNCATED AT 250 WORDS)
在戊巴比妥麻醉、切断迷走神经并预先用神经节阻滞剂处理的犬中,研究了多巴酚丁胺的变力性选择性。目的是确定在六甲铵存在且切断迷走神经的情况下,多巴酚丁胺的变力性选择性是否可归因于多巴酚丁胺对α-肾上腺素能受体的作用。在用六甲铵(20mg/kg)处理30分钟后,测定异丙肾上腺素或多巴酚丁胺的剂量-反应曲线。心率与右心室收缩力的分析表明,对于给定的收缩力增加,多巴酚丁胺引起的心动过速比异丙肾上腺素少;当收缩力增加50%或100%时,这具有统计学意义。在另一系列实验中,在普萘洛尔(3mg/kg)给药20分钟后给予多巴酚丁胺(8μg·kg⁻¹·min⁻¹)。在这些条件下,收缩力有轻微增加,相当于普萘洛尔给药前多巴酚丁胺反应的12%。普萘洛尔存在时收缩力的这种增加被酚妥拉明(1mg/kg)完全阻断。因此,在另一系列实验中,在单独给予酚妥拉明(1mg/kg)或赋形剂之前和30分钟后,在六甲铵存在的情况下进行多巴酚丁胺的剂量-反应曲线实验。酚妥拉明不影响多巴酚丁胺对心率或收缩力的作用,但可防止多巴酚丁胺引起的心舒张期血压升高。此外,心率与收缩力的分析表明,酚妥拉明对多巴酚丁胺的变力性选择性没有统计学上的显著影响。(摘要截断于250字)